We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byGeraldine Gibson
Modified over 4 years ago
Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population- Based Analysis Babatunde A. Yerokun, MD, Zhifei Sun, MD, Chi-Fu Jeffrey Yang, MD, Brian C. Gulack, MD, Paul J. Speicher, MD, Mohamed A. Adam, MD, Thomas A. D’Amico, MD, Mark W. Onaitis, MD, David H. Harpole, MD, Mark F. Berry, MD, Matthew G. Hartwig, MD The Annals of Thoracic Surgery Volume 102, Issue 2, Pages (August 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Forest plot of factors associated with use of minimally invasive esophagectomy (MIE). Black squares represent odds ratios for the independent association of each factor with using MIE; 95% confidence interval bounds are represented by the corresponding horizontal lines. Factors to the right of the vertical line at 1.0 are independently associated with using MIE. Patients receiving care at an academic or comprehensive institution are associated with use of minimally invasive esophagectomies, whereas patients with cT2 and cT3 tumors were associated with use of open esophagectomy (OE). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Survival of open esophagectomy (OE) versus minimally invasive esophagectomy (MIE) and standard minimally invasive esophagectomy (SMIE) versus robotic-assisted minimally invasive esophagectomy (RAMIE), stratified by histologic type. (A) Adenocarcinoma: OE versus MIE; (B) adenocarcinoma: SMIE versus RAMIE; (C) squamous cell carcinoma: OE versus MIE; (D) squamous cell carcinoma: SMIE versus RAMIE. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non–small cell lung cancer Babatunde A. Yerokun, MD, Chi-Fu.
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,
Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Nathan M. Mollberg, DO,
Masatsugu Hamaji, MD, Syed Osman Ali, MD, Bryan M. Burt, MD
Benny Weksler, MD, Jennifer L. Sullivan, MD
Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C
Trevor Williams, MD, MPH, Brian C
Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J
Emergent Esophagectomy for Esophageal Perforations: A Safe Option
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD
Minimally Invasive Versus Sternotomy Approach for Mitral Valve Surgery in Patients Greater Than 70 Years Old: A Propensity-Matched Comparison David M.
How to Keep the Treatment of Esophageal Disease in the Surgeon’s Hands
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma After Esophagectomy San-Gang Wu, MD, Feng-Yan Li, MD,
Gal Levy, MD, Mark A. Cordes, MD, Alexander S. Farivar, MD, Ralph W
Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery
Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.
© 2023 SlidePlayer.com Inc. All rights reserved.